Final Programme - iuphar

FC01 Clinical pharmacology in the emerging countries
Leader: Lembit Rägo, (Switzerland)
FC01.3 Clinical trials in countries with developing and emerging economies
Chair: Lembit Rägo, (Switzerland)
09:30 - 09:55 FC01.3.1 Global drug development in Singapore: regulatory perspective
Yang-Tong Foo, (Singapore)
09:55 - 10:20 FC01.3.2 Ethical issues related to the clinical trials outside ICH regions.
Juntra Karbwang-Laothavorn, (Switzerland)
10:20 - 10:45 FC01.3.3 Clinical trials registries in countries with emerging and developing economies
Davina Ghersi, (Switzerland)
10:45 - 11:15 COFFEE BREAK
11:15 - 11:30 FC01.3.4 Free Communication Presentation:
The role of CYP2B6 genetic polymorphisms in predicting toxicity from cyclophosphamide
based therapy in Lebanese patients with breast cancer or Non-Hodgkin’s Lymphoma
F Haroun, H Hatoum, A Bazarbachi, A Shamseddin, Z Salem, A Taher, N El Saghir,
A Tfayli, Nathalie Zgheib, (Lebanon)
11:30 - 11:45 FC01.3.5 Free Communication Presentation:
Evaluation of the effect of intramuscular dexamethasone injection on the duration of
labor and its adverse effects
Maryam Kashanian, (Iran), F Dadkhah, F Mokhtari
11:45 - 12:00 FC01.3.6 Free Communication Presentation:
Randomized, double blind, placebo controlled, evaluation of albendazole in patients with
single enhancing lesions (SELs)
Sandeep Kaushal, (India), S Kaur, S Tandon, SC Chopra, G Singh
12:00 - 12:15 FC01.3.7 Free Communication Presentation:
Zagreb medical students’ attitudes towards online learning resources on medical
therapeutics
Robert Likic, (Croatia), L Bielen, V Erdeljic, KM Ausperger, MR Aumiler, D Juricic,
I Francetic, S Maxwell
62 Tuesday 20 July ■ 09:30 - 12:15 ■ Auditorium 10